HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

vorinostat (suberoylanilide hydroxamic acid)

inhibits histone deacetylase I & 3; structure in first source
Also Known As:
suberoylanilide hydroxamic acid; M344; Merck brand of Vorinostat; N-hydroxy-N'-phenyloctanediamide; NHNPODA; Zolinza; suberanilohydroxamic acid; N-Hydroxy-N'-phenyl octanediamide
Networked: 875 relevant articles (65 outcomes, 241 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Grant, Steven: 25 articles (05/2014 - 12/2003)
2. Richon, Victoria M: 24 articles (07/2015 - 05/2002)
3. Marks, Paul A: 23 articles (04/2012 - 05/2002)
4. Dent, Paul: 18 articles (05/2014 - 12/2003)
5. Espinoza-Delgado, Igor: 16 articles (10/2015 - 04/2009)
6. Li, Yongqing: 12 articles (04/2015 - 11/2009)
7. Liu, Baoling: 12 articles (04/2015 - 11/2009)
8. Alam, Hasan B: 12 articles (04/2015 - 11/2009)
9. Dai, Yun: 10 articles (06/2013 - 12/2003)
10. Johnstone, Ricky W: 9 articles (11/2015 - 07/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
3. Leukemia
4. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Histone Deacetylase Inhibitors
2. vorinostat (suberoylanilide hydroxamic acid)
3. trichostatin A (A 300)
4. Histone Deacetylases (Histone Deacetylase)
5. bortezomib (Velcade)
6. Valproic Acid (Valproate, Semisodium)
7. Paclitaxel (Taxol)
8. Proteasome Endopeptidase Complex (Proteasome)
9. Butyrates (Butyrate)
10. Sodium

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radiotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Transplants (Transplant)
5. Molecular Targeted Therapy